Home > Products > CD16 & EGFR
> Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-IgG)
Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-IgG) (CAT#: BSIG-036)
Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD16 and anti-EGFR parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget NK cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Anti-CD16 x Anti-EGFR Bispecific Antibody (IgG-IgG) (BSIG-036). Click the button below to contact us or submit your feedback about this product.